DK1663267T3 - Orale sammensætninger til behandling af cellulite - Google Patents

Orale sammensætninger til behandling af cellulite

Info

Publication number
DK1663267T3
DK1663267T3 DK04786933T DK04786933T DK1663267T3 DK 1663267 T3 DK1663267 T3 DK 1663267T3 DK 04786933 T DK04786933 T DK 04786933T DK 04786933 T DK04786933 T DK 04786933T DK 1663267 T3 DK1663267 T3 DK 1663267T3
Authority
DK
Denmark
Prior art keywords
treatment
cellulite
oral compositions
complexed
phospholipids
Prior art date
Application number
DK04786933T
Other languages
Danish (da)
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1663267T3 publication Critical patent/DK1663267T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK04786933T 2003-09-19 2004-09-10 Orale sammensætninger til behandling af cellulite DK1663267T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001789A ITMI20031789A1 (it) 2003-09-19 2003-09-19 Composizioni farmaceutiche e cosmetiche per il trattamento
PCT/EP2004/010148 WO2005027947A1 (en) 2003-09-19 2004-09-10 Oral compositions for the treatment of cellulite

Publications (1)

Publication Number Publication Date
DK1663267T3 true DK1663267T3 (da) 2007-07-30

Family

ID=34362407

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04786933T DK1663267T3 (da) 2003-09-19 2004-09-10 Orale sammensætninger til behandling af cellulite

Country Status (22)

Country Link
US (1) US7691422B2 (sl)
EP (1) EP1663267B1 (sl)
JP (1) JP5537764B2 (sl)
KR (2) KR20110047280A (sl)
CN (1) CN100566734C (sl)
AT (1) ATE357925T1 (sl)
AU (1) AU2004273598B2 (sl)
CA (1) CA2539229C (sl)
CY (1) CY1106561T1 (sl)
DE (1) DE602004005603T2 (sl)
DK (1) DK1663267T3 (sl)
ES (1) ES2285528T3 (sl)
HK (1) HK1093901A1 (sl)
IL (1) IL174353A0 (sl)
IT (1) ITMI20031789A1 (sl)
NO (1) NO334499B1 (sl)
NZ (1) NZ545972A (sl)
PL (1) PL1663267T3 (sl)
PT (1) PT1663267E (sl)
RU (1) RU2355389C2 (sl)
SI (1) SI1663267T1 (sl)
WO (1) WO2005027947A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT104241B (pt) 2008-10-29 2012-03-06 Stargate Produtos Farmaceuticos Dieteticos E Nutricionais Lda Composições incorporando agentes redutores da celulite e inestetismos associados e formulações que as contêm
CN104906153A (zh) * 2015-06-09 2015-09-16 邳州鑫源生物制品有限公司 一种高效提取银杏黄酮的工艺方法
CN104940253A (zh) * 2015-06-29 2015-09-30 兰捷 一种从银杏叶中提取高纯度总黄酮的方法
KR20200115927A (ko) * 2019-03-29 2020-10-08 주식회사 유니베라 포도잎 추출물 및 병풀 추출물을 포함하는 정맥순환 장애 개선용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1203515B (it) 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
BR0017224A (pt) 2000-04-18 2003-01-07 Ceteris Holding B V Amsterdam Composição baseada em extratos naturais útil na prevenção e tratamento de rugas cutaneas
AU2002258649A1 (en) 2001-03-30 2002-10-28 Rhodia Inc. Aqeuous suspension of nanoparticles comprising an agrochemical active ingredient
ITMI20011022A1 (it) * 2001-05-17 2002-11-17 Indena Spa Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
ITMI20031427A1 (it) 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi, loro uso in campo farmaceutico e cosmetico e formulazioni che li contengono

Also Published As

Publication number Publication date
US7691422B2 (en) 2010-04-06
US20060292249A1 (en) 2006-12-28
JP2007505850A (ja) 2007-03-15
PT1663267E (pt) 2007-06-25
PL1663267T3 (pl) 2007-08-31
RU2355389C2 (ru) 2009-05-20
NO20061223L (no) 2006-04-19
CA2539229A1 (en) 2005-03-31
WO2005027947A1 (en) 2005-03-31
EP1663267A1 (en) 2006-06-07
KR20060101456A (ko) 2006-09-25
RU2006108386A (ru) 2006-09-10
IL174353A0 (en) 2006-08-01
JP5537764B2 (ja) 2014-07-02
DE602004005603T2 (de) 2008-01-24
ES2285528T3 (es) 2007-11-16
ITMI20031789A1 (it) 2005-03-20
DE602004005603D1 (de) 2007-05-10
EP1663267B1 (en) 2007-03-28
KR20110047280A (ko) 2011-05-06
CA2539229C (en) 2015-07-21
AU2004273598B2 (en) 2009-10-08
ATE357925T1 (de) 2007-04-15
SI1663267T1 (sl) 2007-06-30
CN1852726A (zh) 2006-10-25
NO334499B1 (no) 2014-03-17
HK1093901A1 (en) 2007-03-16
CY1106561T1 (el) 2012-01-25
NZ545972A (en) 2009-04-30
AU2004273598A1 (en) 2005-03-31
CN100566734C (zh) 2009-12-09
KR101186096B1 (ko) 2012-09-25

Similar Documents

Publication Publication Date Title
HK1069102A1 (en) Pharmeceutical and cosmetic compositions against skin aging
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
HK1063295A1 (en) Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
NO20052490L (no) Dagsdoseringsenheter for melatonin.
NO20060152L (no) Kombinasjoner av vasoaktive agenser, deres anvendelse innen farmasi og kosmetikk, og formuleringer inneholdende dem
NO20040536L (no) Orale sammensetninger til behandling av hodebunnslidelse
WO2008025830A3 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
HK1093901A1 (en) Oral compositions for the treatment of cellulite
CL2004000499A1 (es) Uso de una composicion que comprende extracto de panax ginseng (ginseng chino) y paullinia cupana (guarana) para la preparacion de un medicamento o suplemento dietetico util para mejorar las habilidades cognitivas; la composicion farmaceutica y suple
ATE489073T1 (de) Melatonin-tagesdosierungseinheiten
ITMI20050874A1 (it) Composizioni cosmetiche e farmaceutiche contenenti estratti di echinacea di terminalia o altre piante ricche in saponine triterpeniche e derivati dalla vitamina c
UA43011A (uk) Лікувальний засіб "агмелгін"
CL2009000609A1 (es) Producto farmaceutico combinado trifasico con 24 unidades de dosificacion, en donde la cantidad de drospirenona durante las tres fases es constante y la cantidad de 17 beta-estradiol aumenta de 1 mg a 2 mg, ademas de 4 unidades de dosificacion de placebo o sin unidades de dosificacion; kit farmaceutico.
BRPI0415157A (pt) composição sinérgica para o clareamento da pele e uso de uma composição